Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Newstrike Brands Ltd NWKRF

"Newstrike Brands Ltd is a licensed producer and cultivator of medical cannabis based in Brantford, Ontario. The company cultivates and sells both forms including dried and fresh marihuana."


OTCPK:NWKRF - Post by User

Post by thorgb1on Jan 18, 2018 4:01pm
544 Views
Post# 27387943

What I think is happening....

What I think is happening....Wanted to drop this in here, posted it on the CMED board. I was a long time shareholder of HIP, but sold when it ran 2-3 bucks, just could not see a reason to hold on as I thought it was greatly inflated  given the CMED deal. Regardless, I like Jay and the HIP team, soI want to see them get a win too, so hopefully it all works out for everyone.....

Look at the sequence of events and what the market is saying with how this is trading to figure out what is happening.

1. CMED and HIP halted this morning, meaning their is a material event affecting both companies. It's only logical that CMED has achieved 51% of shareholders in favour of the HIP acquisition, Otherwise why would they halt today, and not tomorrow which is when the voting was scheduled to close, or even next week. Also, with shareholder consent for the HIP acquisition, the non-solicitation clause from the CMED-HIP agreement is finished.
2. The CMED board must have met and with the knowledge that they have shareholder consent to complete the HIP acquisition and also with the knowledge that they are under an offer from ACB. Knowing what they do, I would think that they would have to approach ACB and explain the New status, and give ACB the opportunity to respond and revise their offer if they so choose. Not doing this would have been a breach of their fiduciary responsibility to act in the best interests of the shareholders!
3. ACB now has options:
-walk away
-revise the offer for CMED only
-submit an offer for CMED + HIP

Happy to listen to any other scenarios, but the above is the only thing that makes any sense based on the market activity and the timing of events. Don't know how it plays out and don't care at this point, it's win-win for CMED. I would think that any revised offer for CMED starts at $40 a CMED share. It's foolish to think it will be 2:1 as some trolls are saying, which would be a significant discount to current market, and much less then what Senvest suggested as fair market value in their letter to the ACB board. All my opinion only, but again it's stem only thing that makes sense at this point. GLTA.
Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.cmed&postid=27387714#k0wuFMmCV3de34Sq.99
<< Previous
Bullboard Posts
Next >>